Astrazeneca Share News (AZN)
AZN Share
AZN Share
AZN Share
AZN Share
AZN
AZN Share
AZN Level 2
AZN Live
AZN Broker
AZN Directors
AZN Financial
AZN
AZN Short
AZN
Last checked at -
(Sharecast News) - AstraZeneca said its Imfinzi treatment did not produce a significant improvement for cervical cancer patients over treatment by chemoradiotherapy (CRT) on its own.
Read more
March 23 (Reuters) - Europe's drug regulator is expected to give the go-ahead this week for AstraZeneca's antibody-based injection for preventing COVID-19 infections, two people familiar with the review said, following U.S. and UK approvals.
Read moreMarch 21 (Reuters) - The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that has yet to be certified by peer review.
Read moreMarch 21 (Reuters) - The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that has yet to be certified by peer review.
Read more
| Tuesday 22 March | |
| Unilever PLC | dividend payment date |
| Wednesday 23 March | |
| no events scheduled | |
| Thursday 24 March | |
| British American Tobacco PLC | ex-dividend date |
| Close Brothers Group PLC | ex-dividend date |
| CLS Holdings PLC | ex-dividend date |
| Craneware PLC | ex-dividend date |
| Ferguson PLC | ex-dividend date |
| Greggs PLC | special ex-dividend date |
| IDOX plc | ex-dividend date |
| Jersey Electricity PLC | dividend payment date |
| Mid Wynd International Investment Trust PLC | ex-dividend date |
| Nichols PLC | ex-dividend date |
| OSB Group PLC | ex-dividend date |
| Palace Capital PLC | ex-dividend date |
| Pearson PLC | ex-dividend date |
| Prudential PLC | ex-dividend date |
| Schroders PLC | ex-dividend date |
| Volution Group PLC | ex-dividend date |
| XP Power Ltd | ex-dividend date |
| Friday 25 March | |
| BP PLC | dividend payment date |
| City of London Investment Group PLC | dividend payment date |
| City of London Investment Group PLC | special dividend payment date |
| Dunedin Enterprise Investment Trust PLC | dividend payment date |
| Empiric Student Property PLC | dividend payment date |
| Foresight Group Holdings Ltd | dividend payment date |
| FRP Advisory Group PLC | dividend payment date |
| Henderson Opportunities Trust PLC | dividend payment date |
| Honeycomb Investment Trust PLC | dividend payment date |
| JLEN Environmental Assets Group Ltd | dividend payment date |
| Jupiter Emerging & Frontier Income Trust PLC | dividend payment date |
| LXI REIT PLC | dividend payment date |
| Mattioli Woods PLC | dividend payment date |
| Real Estate Credit Investments Ltd | dividend payment date |
| RM Infrastructure Income PLC | dividend payment date |
| Ruffer Investment Co Ltd | dividend payment date |
| Schroder Real Estate Investment Trust Ltd | dividend payment date |
| Triple Point Social Housing REIT PLC | dividend payment date |
| Utilico Emerging Markets Trust PLC | dividend payment date |
| Monday 28 March | |
| AstraZeneca PLC | dividend payment date |
| Diversified Energy Co PLC | dividend payment date |
| Mountview Estates PLC | dividend payment date |
| Copyright 2022 Alliance News Limited. All Rights Reserved. | |
March 18 (Reuters) - Bristol Myers Squibb Co, in a lawsuit made public on Friday, said AstraZeneca's cancer treatment Imfinzi violates patents related to its blockbuster cancer drug Opdivo.
Read moreMarch 18 (Reuters) - The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that has yet to be certified by peer review.
Read moreMarch 18 (Reuters) - AstraZeneca Pharmaceuticals LP's cancer treatment Imfinzi violates patents related to Bristol-Myers Squibb Co's blockbuster cancer drug Opdivo, Bristol-Myers said in a lawsuit made public on Friday in Delaware federal court.
Read moreMarch 17 (Reuters) - Britain's medicines regulator has approved AstraZeneca's antibody-based COVID-19 treatment for preventing infections in adults with poor immune response, marking a major step in the fight against the pandemic as infections surge globally.
Read more(Alliance News) - AstraZeneca PLC on Thursday said its Alexion subsidiary has reached a settlement agreement with Roche Holding AG's Chugai Pharmaceutical Co Ltd resolving all patent disputes between the two related to rare blood disease drug Ultomiris.
Read more(Sharecast News) - Drugmaker AstraZeneca's rare disease unit has entered into a settlement agreement with Chugai Pharmaceutical, resolving all patent disputes between the two companies related to long-acting C5 complement inhibitor, Ultomiris (ravulizumab).
Read more(Alliance News) - AstraZeneca PLC and Merck & Co Inc on Wednesday said their jointly-developed Lynparza drug reduces the risk of death in a form of breast cancer.
Read moreMarch 16 (Reuters) - The World Trade Organization (WTO) praised a provisional deal to waive patent rights for COVID-19 vaccines after more than a year of deadlock, though drugmakers said the move risked undermining the industry's ability to respond to future health crises.
Read moreMarch 14 (Reuters) - The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that has yet to be certified by peer review.
Read moreMarch 14 (Reuters) - Sanofi's shares slid 5% on Monday after a drug candidate to fight a common type of breast cancer failed to slow progression of the disease in a clinical trial, knocking confidence in the French drugmaker's drug development prowess.
Read more
Last checked at